Posts

Three takeaways from Isomorphic Labs’ historic $5B raise

White House withdraws Heidi Overton’s FDA nomination

Pfizer licenses Starna’s early-stage in vivo CAR-T programs

Novartis previews hematology and breast cancer data at ASH and SABCS

Siemens Healthineers and Sana Kliniken launch AI collaboration

Cradle platform use expands across argenx antibody discovery programs

Priavoid’s Alzheimer’s pill misses its Phase 2 primary efficacy target

Lilly and Stipple Bio announce oncology deal worth up to $5.9 billion

Emerging biotech hubs compete on more than cost

Flagship commits £100 million to launch AI biotech lab in London

Sofinnova closes €725M fund for late-stage life sciences companies

CG Oncology reports strong Phase 3 bladder cancer results

J&J to acquire Ollin Biosciences for up to $3.33 billion